Latest PBPK Modeling Platform Advances Drug Development
In the ever-evolving pharmaceutical landscape, advancing drug development requires innovative tools that seamlessly integrate science…
CertaraApril 23, 2024
Certara Announces Inaugural Client Conference with Keynote by Dr. Scott Gottlieb
Agenda features discussion of life sciences industry trends, business value of model-informed drug development strategies,…
CertaraApril 18, 2024
The Challenges and Opportunities of Rare Disease Drug Development
This whitepaper by drug development experts reflect on some of these challenges and opportunities in…
CertaraApril 18, 2024
Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software Platform
PRINCETON, NJ – April 16, 2024 – Certara, Inc. (Nasdaq: CERT), a global leader in…
CertaraApril 16, 2024
Certara Announces New Corporate Headquarters
New, spacious location in Radnor, Pennsylvania will support the needs of company’s growing workforce and…
CertaraApril 15, 2024
What are biosimilars & how are they developed?
Learn about biosimilars, their benefits for patients who take biologic drugs, and how pharmaceutical companies…
CertaraApril 15, 2024
Exploring ADC pharmacokinetics using QSP
The Pharmacokinetics (PK) of ADC therapeutics typically show a discrepancy between the PK of total…
CertaraApril 12, 2024
